Related Experiment Video
Updated: Jun 25, 2026

10:13
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Gaussia luciferase: A highly unusual enzyme.
Jakob R Winther1, Fenne M Dijkema1, Sylvester K Vinther1
1Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Ole Maaløes vej 5, Copenhagen DK-2200, Denmark.
Biochimica Et Biophysica Acta. Proteins and Proteomics
|June 23, 2026
Summary
Gaussia princeps luciferase is a bright reporter protein. Its unusual disordered structure and rapid inactivation present challenges for enzymatic studies and consistent bioluminescence assays.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Gaussia princeps luciferase is a small, bright reporter protein widely used in life sciences.
- Research has focused on developing improved variants and understanding its luminescence properties.
- However, fundamental questions about its structure, mechanism, and stability remain.
Purpose of the Study:
- To examine past research on Gaussia luciferase in light of recent findings.
- To discuss the implications of its unique structural and stability characteristics for its application.
- To emphasize the need for consistent assays and improved evaluation of mutant variants.
Main Methods:
- Structural analysis of Gaussia luciferase.
- Investigation of its enzymatic mechanism and substrate oxidation.
- Review of existing literature on Gaussia luciferase variants and applications.
Main Results:
- Gaussia luciferase exhibits extensive disorder and lacks a significant hydrophobic core.
- Its substrate binding site remains difficult to identify, and the enzymatic mechanism is unclear.
- The enzyme undergoes rapid, irreversible inactivation upon coelenterazine oxidation.
Conclusions:
- The unique structural and stability features of Gaussia luciferase pose fundamental enzymology questions.
- These characteristics have significant implications for the reliability of bioluminescence-based reporting assays and high-throughput screening.
- Further research is needed to ensure consistent assay performance and accurate evaluation of mutant variants.

